INDV vs TMDX: fair value comparison
Indivior Pharmaceuticals, Inc. and TransMedics Group, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, TMDX currently sits closer to the top of our discount ranking. TMDX carries the stronger quality grade.
| INDV | TMDX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $37.37 | $81.55 |
| 12-month range | $23.46–$40.25 | $67.53–$150.42 |
| Sector rank | #29 of 113 Healthcare | #26 of 113 Healthcare |
| Quality grade | F | A |
| Momentum grade | — | A |
| Leverage | Low | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | High |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: INDV fair value analysis · TMDX fair value analysis